Hemorrhage Countermeasure Evaluation Capabilities RFI
Dept of Defense · DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA)
This notice is not accepting responses (deadline was May 4, 2026, 4:00 PM EDT).
Page kept for research and related open opportunities below. For current work in this category, use the related notices or browse hubs.
- Response deadline
- May 4, 2026, 4:00 PM EDT
- Posted
- Apr 9, 2026
- Solicitation
- DARPA-SN-26-61
- Set-aside
- None listed
- Place of performance
- —
- Contracting office
- DEF ADVANCED RESEARCH PROJECTS AGCY · ARLINGTON · VA
- Source
- SAM.gov · updated Jul 5, 2026
Description
The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA) seeks input from industry and academia regarding capabilities for providing independent verification and validation, clinical trial, and commercialization support for hemorrhage countermeasures. This Request for Information (RFI) is a preliminary step to identify potential partners capable of providing third-party assessments of safety and efficacy of potential hemorrhage countermeasures and assisting in development strategies to ensure said products transition from the laboratory to civilian and government markets after research, development, testing, and evaluation (RDT&E) efforts have ended. DARPA is particularly interested in respondents who can address all the above task domains to allow one provider to have comprehensive knowledge about the data for efficiency and to tailor commercialization and regulatory strategies.
What similar awards have paid
Real federal awards already on the books in a similar lane — so you can size the opportunity, not guess. This is public history, not a bid price, cost estimate, or prediction that you will win.
Typical award size
$404,976
Middle of the pack for similar past awards
Most similar awards fall between $45,429 and $2.81M
Who has won work like this
Public awardees in this lane — useful for competitor scan or teaming ideas, not a ranked list of “best” firms.
- 1ADVANCED TECHNOLOGY INTERNATIONAL5 awards$2.27B
- 2AMGEN USA INC2 awards$714.70M
- 3SIGA TECHNOLOGIES, INC.1 award$624.44M
- 4ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.5 awards$383.82M
- 5ALLUCENT GOVERNMENT SERVICES (US) LLC5 awards$375.68M
- 6TECHNICAL RESOURCES INTERNATIONAL, INC.9 awards$363.64M
- 7MAPP BIOPHARMACEUTICAL, INC.4 awards$315.08M
- 8ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE)2 awards$305.87M
Drawn from official USAspending contract records in our index. Always confirm requirements on the SAM.gov notice before you bid.
Intelligence only — not legal advice or a guarantee of award. Always verify requirements on the official SAM.gov notice. Past award amounts are public history, not a suggested bid or prediction. Notice ID bfe4d37cb3064e30b2a14f9183c35fbf.